MetaCap

Maravai LifeSciences (MRVI) Stock Chart

NASDAQ: MRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.21-0.22 (-2.96%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

MRVI technical summary

MRVI is trading 0.8% above its 50-day simple moving average of $7.16 and 46.1% above its 200-day average of $4.93. The 50-day average is above the 200-day average, a configuration technical analysts associate with a longer-term uptrend. The 14-day Relative Strength Index (RSI) is 46.8, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $2.55 (Nov 7, 2025) to $9.42 (Aug 26, 2026); the current price sits 68% of the way from the low to the high. Annualized 30-day volatility is 63.1%. Based on the last session's high, low and close, the classic pivot point is $7.20, with first resistance at $7.38 and first support at $7.02.

These indicators describe past price behavior for Maravai LifeSciences; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
9.42 (Aug 26)
1Y low
2.55 (Nov 7)
Last close
7.21

MRVI price performance

1 week

-3.87%

1 month

+0.28%

3 months

+20.77%

6 months

+131.83%

Year to date

+121.85%

1 year

+116.52%

3 years

-7.21%

5 years

-80.56%

MRVI price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day7.78Price below7.57Price below
10-day7.70Price below7.60Price below
20-day7.39Price below7.51Price below
50-day7.16Price above7.14Price above
100-day6.40Price above6.44Price above
200-day4.93Price above5.27Price above

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)7.74
Resistance 2 (R2)7.56
Resistance 1 (R1)7.38
Pivot point7.20
Support 1 (S1)7.02
Support 2 (S2)6.84
Support 3 (S3)6.66

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis